Don V. Jackson

2.6k total citations
75 papers, 2.0k citations indexed

About

Don V. Jackson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Don V. Jackson has authored 75 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 19 papers in Epidemiology. Recurrent topics in Don V. Jackson's work include Cancer Treatment and Pharmacology (23 papers), Lung Cancer Research Studies (16 papers) and Neuroendocrine Tumor Research Advances (15 papers). Don V. Jackson is often cited by papers focused on Cancer Treatment and Pharmacology (23 papers), Lung Cancer Research Studies (16 papers) and Neuroendocrine Tumor Research Advances (15 papers). Don V. Jackson collaborates with scholars based in United States and United Kingdom. Don V. Jackson's co-authors include Charles L. Spurr, Hyman B. Muss, Frederick Richards, M. Robert Cooper, Dougľas R. White, Richard A. Bender, John J. Stuart, V.Sagar Sethi, Mark Allen O’Rourke and Paul J. Catalano and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Don V. Jackson

75 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Don V. Jackson United States 27 1.3k 508 337 283 270 75 2.0k
F. Ries Luxembourg 21 622 0.5× 325 0.6× 330 1.0× 323 1.1× 256 0.9× 70 1.7k
Massimo Lopez Italy 21 1.6k 1.2× 598 1.2× 405 1.2× 213 0.8× 516 1.9× 59 2.2k
R. G. Hahn United States 19 1.2k 0.9× 643 1.3× 396 1.2× 262 0.9× 181 0.7× 45 1.9k
Dusan Kotasek Australia 28 1.2k 0.9× 542 1.1× 448 1.3× 371 1.3× 282 1.0× 104 2.3k
Per‐Ebbe Jönsson Sweden 20 927 0.7× 434 0.9× 239 0.7× 131 0.5× 270 1.0× 35 1.5k
S P Balcerzak United States 25 1.5k 1.2× 1.3k 2.6× 511 1.5× 609 2.2× 119 0.4× 64 2.9k
F. Calabresi Italy 21 910 0.7× 273 0.5× 285 0.8× 191 0.7× 121 0.4× 52 1.5k
C.J. van Groeningen Netherlands 22 1.1k 0.8× 590 1.2× 522 1.5× 157 0.6× 208 0.8× 49 2.4k
W G Harker United States 24 1.3k 1.0× 428 0.8× 736 2.2× 181 0.6× 190 0.7× 35 2.3k
S Hellman United States 13 806 0.6× 411 0.8× 453 1.3× 359 1.3× 445 1.6× 23 1.9k

Countries citing papers authored by Don V. Jackson

Since Specialization
Citations

This map shows the geographic impact of Don V. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don V. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don V. Jackson more than expected).

Fields of papers citing papers by Don V. Jackson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don V. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don V. Jackson. The network helps show where Don V. Jackson may publish in the future.

Co-authorship network of co-authors of Don V. Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Don V. Jackson. A scholar is included among the top collaborators of Don V. Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Don V. Jackson. Don V. Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berry, William R., et al.. (2006). A Phase II Study of Weekly Paclitaxel/Estramustine/Carboplatin in Hormone-Refractory Prostate Cancer. Clinical Genitourinary Cancer. 5(2). 131–137. 19 indexed citations
2.
Berry, William R., James W. Hathorn, Shaker R. Dakhil, et al.. (2004). Phase II Randomized Trial of Weekly Paclitaxel with or Without Estramustine Phosphate in Progressive, Metastatic, Hormone-Refractory Prostate Cancer. PubMed. 3(2). 104–111. 35 indexed citations
3.
Michalets, Elizabeth Landrum & Don V. Jackson. (1997). Diltiazem‐Associated Thrombocytopenia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(6). 1345–1348. 1 indexed citations
4.
Jackson, Don V., et al.. (1992). Fluoxymesterone as Third Line Endocrine Therapy for Advanced Breast Cancer A Phase II Trial of the Piedmont Oncology Association. American Journal of Clinical Oncology. 15(3). 233–235. 4 indexed citations
5.
Muss, Hyman B., L. Douglas Case, Robert L. Capizzi, et al.. (1990). High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.. Journal of Clinical Oncology. 8(11). 1797–1805. 61 indexed citations
6.
White, Dougľas R., Bayard L. Powell, Robert K. Stuart, et al.. (1990). A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A piedmont oncology association study. Cancer. 65(8). 1700–1703. 5 indexed citations
7.
Jackson, Don V., Marcus E. Randall, & Frederick Richards. (1988). Spinal cord compression due to extramedullary hematopoiesis in thalassemia: Long-term follow-up after radiotherapy. Surgical Neurology. 29(5). 389–392. 47 indexed citations
8.
Richards, Fred, L. Douglas Case, Dougľas R. White, et al.. (1986). Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.. Journal of Clinical Oncology. 4(4). 565–570. 23 indexed citations
9.
Jackson, Don V., et al.. (1985). Phase II study of vincristine infusion in refractory small cell carcinoma of the lung. American Journal of Clinical Oncology. 8(2). 154–156. 2 indexed citations
10.
Powell, Bayard L., Don V. Jackson, Charles W. Scarantino, et al.. (1985). Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: A preliminary analysis. International Journal of Radiation Oncology*Biology*Physics. 11(3). 457–462. 10 indexed citations
11.
Jackson, Don V., Eugene Paschold, Charles L. Spurr, et al.. (1984). Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion. Cancer. 53(12). 2601–2606. 36 indexed citations
12.
Jackson, Don V., et al.. (1984). Hepatic intra-arterial infusion of vincristine. Cancer Chemotherapy and Pharmacology. 13(2). 120–122. 1 indexed citations
13.
Muss, Hyman B., John J. Stuart, Don V. Jackson, et al.. (1984). Bone marrow evaluation in small cell lung cancer. American Journal of Clinical Oncology. 7(1). 59–64. 7 indexed citations
14.
Jackson, Don V., Wayne Meredith, V.Sagar Sethi, et al.. (1983). Continuous intravenous infusion of vinca alkaloid using a subcutaneously implanted pump in a canine model. Cancer Chemotherapy and Pharmacology. 10(3). 217–220. 5 indexed citations
15.
Jackson, Don V., H. Bradley Wells, Dougľas R. White, et al.. (1983). Lack of potentiation of vincristine-induced neurotoxicity by VP-16–213. American Journal of Clinical Oncology. 6(3). 327–330. 13 indexed citations
16.
Jackson, Don V., Dougľas R. White, Hyman B. Muss, et al.. (1983). Vincristine by continuous infusion in refractory breast cancer. American Journal of Clinical Oncology. 6(5). 529–532. 3 indexed citations
17.
Muss, Hyman B., Frederick Richards, M. Robert Cooper, et al.. (1982). Nonseminomatous germ cell cancer of the testis. Reducing treatment-related morbidity in patients with disseminated disease. Cancer. 50(9). 1742–1745. 4 indexed citations
18.
19.
Richards, Frederick, M. Robert Cooper, Dougľas R. White, et al.. (1980). Advanced epidermoid lung cancer. Prolonged survival after chemotherapy. Cancer. 46(1). 34–37. 2 indexed citations
20.
Muss, Hyman B., Dougľas R. White, Frederick Richards, et al.. (1978). Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer. A randomized trial. Cancer. 42(5). 2141–2148. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Ries Breakdown of academic impact, for papers by Massimo Lopez Breakdown of academic impact, for papers by R. G. Hahn Breakdown of academic impact, for papers by Dusan Kotasek Breakdown of academic impact, for papers by Per‐Ebbe Jönsson Breakdown of academic impact, for papers by S P Balcerzak Breakdown of academic impact, for papers by F. Calabresi Breakdown of academic impact, for papers by C.J. van Groeningen Breakdown of academic impact, for papers by W G Harker Breakdown of academic impact, for papers by S Hellman
Rankless by CCL
2026